Schistosomiasis in African infants and preschool children: Let them now be treated!

Trends in Parasitology

Volumn 29, Issue 4, 2013, Pages 197-205

  Stothard, J Russell ^a   Sousa Figueiredo, José C ^a,b   Betson, Martha ^c   Bustinduy, Amaya ^a   Reinhard Rupp, Jutta ^d  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

^d MERCK SERONO S A   (Switzerland)

Author keywords

Cure rates; HIV; Malaria; Neglected tropical diseases; Paediatrics; Pharmacokinetics; Praziquantel; Preventive chemotherapy

Indexed keywords

EPIQUANTEL; PRAZIQUANTEL; UNCLASSIFIED DRUG;

CHILDHOOD DISEASE; COHORT ANALYSIS; DRUG FORMULATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; INFANT DISEASE; INFECTION RISK; INTERVIEW; MICROSCOPY; MORBIDITY; PRACTICE GUIDELINE; QUESTIONNAIRE; REVIEW; SCHISTOSOMIASIS;

AFRICA; ANIMALS; ANTHELMINTICS; CHILD, PRESCHOOL; HUMANS; INFANT; PRAZIQUANTEL; PREVALENCE; PUBLIC HEALTH; SCHISTOSOMIASIS;

EID: 84875548888     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.02.001     Document Type: Review

References (64)

1. Stothard J.R., Gabrielli A-F. Schistosomiasis in African infants and preschool children: to treat or not to treat?. Trends Parasitol. 2007, 23:83-86.
2. Johansen M.V., et al. Leave children untreated and sustain inequity!. Trends Parasitol. 2007, 23:568-569.
3. Stothard J.R., Gabrielli A-F. Response to Johansen et al.: Leave children untreated and sustain inequity!. Trends Parasitol. 2007, 23:569-570.
4. World Health Organization (2010) Report of a Meeting to Review the Results of Studies on the Treatment of Schistosomiasis in Preschool-aged Children, pp. 1-23, World Health Organization.
5. Ekpo U.F., et al. Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control. Parasitology 2012, 139:835-841.
6. Garba A., et al. Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop. 2010, 115:212-219.
7. ®) against Schistosoma haematobium and S. mansoni in preschool-aged children in Niger. Acta Trop. 2012, 10.1016/j.actatropica.2012.12.003.
8. Coulibaly J.T., et al. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS Negl. Trop. Dis. 2012, 6:e1917.
9. Sousa-Figueiredo J.C., et al. Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole. Int. Health 2012, 4:95-102.
10. Sousa-Figueiredo J.C., et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl. Trop. Dis. 2012, 6:e1864.
11. Montresor A., et al. Preventive chemotherapy and the fight against neglected tropical diseases. Expert Rev. Anti Infect. Ther. 2012, 10:237-242.
12. Molyneux D.H., et al " Rapid-impact interventions" : how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2005, 2:1064-1070.
13. Hodges M.H., et al. High level of Schistosoma mansoni infection in pre-school children in Sierra Leone highlights the need in targeting this age group for praziquantel treatment. Acta Trop. 2012, 124:120-125.
14. Rollinson, D. et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. (in press).
15. French M.D., et al. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl. Trop. Dis. 2010, 4:e897.
16. Stothard J.R., et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 2011, 138:1593-1606.
17. World Health Organization (2012) SCHISTOSOMIASIS Progress Report 2001-2011 and Strategic Plan 2012-2020, World Health Organization.
18. Doenhoff M.J., et al. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21:659-667.
19. Doenhoff M.J., et al. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 2009, 136:1825-1835.
20. Utzinger J., et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009, 136:1859-1874.
21. Stothard J.R., et al. Progress in paediatric parasitology: a preface to a topic focusing on ever younger subjects. Parasitology 2011, 138:1453-1458.
22. Beauchamp T., Childress J. Medical Ethics 2001, Oxford University Press. 5th edn.
23. Mutapi F., et al. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl. Trop. Dis. 2011, 5:e1143.
24. Navaratnam A.M.D., et al. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Trans. R. Soc. Trop. Med. Hyg. 2012, 106:400-407.
25. Sousa-Figueiredo J.C., et al. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel. Trans. R. Soc. Trop. Med. Hyg. 2010, 104:740-742.
26. Sousa-Figueiredo J.C., et al. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int. Health 2010, 2:103-113.
27. Seto E., et al. Patterns of intestinal schistosomiasis among mothers and young children from Lake Albert, Uganda: water contact and social networks inferred from wearable global positioning system dataloggers. Geospat. Health 2012, 7:1-13.
28. Stothard J.R. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:325-332.
29. Shane H.L., et al. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya. PLoS Negl. Trop. Dis. 2011, 5:e951.
30. McCarthy J.S., et al. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl. Trop. Dis. 2012, 6:e1601.
31. Stothard J.R., et al. Schistosoma mansoni infections in young children: When are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable?. PLoS Negl. Trop. Dis. 2011, 5:e938.
32. Sousa-Figueiredo J.C., et al. The urine Circulating Cathodic Antigen (CCA) dipstick: a valid substitute for microscopy for mapping and point-of-care diagnosis of intestinal schistosomiasis. PLoS Negl. Trop. Dis. 2013, 7:e2008.
33. Stothard J.R., et al. Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges. Parasitology 2009, 136:1665-1675.
34. Verani J.R., et al. Schistosomiasis among young children in Usoma, Kenya. Am. J. Trop. Med. Hyg. 2011, 84:787-791.
35. Webster J.P., et al. Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology 2009, 136:1789-1799.
36. Garba A., et al. Risk factors for Schistosoma haematobium infection and morbidity in two villages with different transmission patterns in Niger. Acta Trop. 2010, 115:84-89.
37. Inyang-Etoh P.C., et al. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:38-44.
38. Opara K.N., et al. Genitourinary schistosomiasis among pre-primary schoolchildren in a rural community within the Cross River Basin, Nigeria. J. Helminthol. 2007, 81:393-397.
39. Betson M., et al. Use of fecal occult blood tests as epidemiologic indicators of morbidity associated with intestinal schistosomiasis during preventive chemotherapy in young children. Am. J. Trop. Med. Hyg. 2012, 87:694-700.
40. Betson M., et al. Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity. Am. J. Trop. Med. Hyg. 2010, 83:1048-1055.
41. Boisier P., et al. Ultrasonographical assessment of morbidity in Schistosomiasis mansoni in Madagascar: a community-based study in a rural population. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:208-212.
42. Stelma F.F., et al. Four years' follow-up of hepatosplenic morbidity in a recently emerged focus of Schistosoma mansoni in northern Senegal. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:29-30.
43. Mohamed-Ali Q., et al. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J. Infect. Dis. 1999, 180:1298-1306.
44. Green H.K., et al. Anaemia in Ugandan preschool-aged children: the relative contribution of intestinal parasites and malaria. Parasitology 2011, 138:1534-1545.
45. Magalhaes R.J., Clements A.C. Mapping the risk of anaemia in preschool-age children: the contribution of malnutrition, malaria, and helminth infections in West Africa. PLoS Med. 2011, 8:e1000438.
46. Sousa-Figueiredo J.C., et al. Measuring morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and urinary tract pathologies. PLoS Negl. Trop. Dis. 2009, 3:e526.
47. Stothard J.R. Female genital schistosomiasis - icebergs of morbidity ahead?. Trends Parasitol. 2012, 28:174-175.
48. Wang W., et al. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol. Res. 2012, 111:1871-1877.
49. Utzinger J., et al. ACTs for schistosomiasis: do they act?. Lancet Infect. Dis. 2010, 10:579-581.
50. Montresor A. Cure rate is not a valid indicator for assessing drug efficacy and impact of preventive chemotherapy interventions against schistosomiasis and soil-transmitted helminthiasis. Trans. R. Soc. Trop. Med. Hyg. 2011, 105:361-363.
51. Reich M.R., Govindaraj R. Dilemmas in drug development for tropical diseases - experiences with praziquantel. Health Policy 1998, 44:1-18.
52. Fenwick A., et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009, 136:1719-1730.
53. Savioli L., et al. Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitology 2009, 136:1677-1681.
54. Hotez P.J., et al. Africa is desperate for praziquantel. Lancet 2010, 376:496-498.
55. Reich M.R. Praziquantel: access to medications. Access: How do Good Health Technologies get to Poor People in Poor Countries? 2008, Harvard Center for Population and Development Studies. L.J. Frost, M.R. Reich (Eds.).
56. Wilson S., Dunne D.W. Advances in our understanding of the epidemiology of Plasmodium and schistosome infection: informing coinfection studies. Curr. Opin. HIV AIDS 2012, 7:225-230.
57. Humphries D., et al. The promise and pitfalls of mass drug administration to control intestinal helminth infections. Curr. Opin. Infect. Dis. 2012, 25:584-589.
58. Keiser J., et al. Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 2011, 138:1620-1632.
59. Namwanje H., et al. The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda. Parasitology 2011, 138:1586-1592.
60. Balen J., et al. Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:1039-1048.
61. Hall A., et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:653-658.
62. Montresor A., et al. Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:542-544.
63. Aagaard-Hansen J., et al. Social science perspectives on schistosomiasis control in Africa: past trends and future directions. Parasitology 2009, 136:1747-1758.
64. Kazibwe F., et al. Transmission studies of intestinal schistosomiasis in Lake Albert, Uganda and experimental compatibility of local Biomphalaria spp. Parasitol. Int. 2010, 59:49-53.